Venkata Lakshmi Narasimha Rao Dammalapati

USPTO Granted Patents = 12 (Patent Applications = 4)

EPO Patents = 4 (Patent Applications = 9)

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 45(Granted Patents)

Location History:

Telangana, IN (2020)
Hyderabad, IN (2017 - 2024)

Company Filing History:

7 out of 64

Laurus Labs Private Limited

Years Active: 2017-2024

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12065426 - Crystalline form of nilotinib hydrochloride, process for its preparation and pharmaceutical composition containing the same (2024-08-20),

2. 12054511 - Synthesis of phosphate derivatives (2024-08-06),

3. 11897913 - Synthesis of 3′-deoxyadenosine-5′-O-[phenyl(benzyloxy-L-alaninyl)]phosphate (NUC-738) (2024-02-13),

4. 11603382 - Diastereoselective synthesis of phosphate derivatives (2023-03-14),

5. 11414452 - Synthesis of phosphate derivatives (2022-08-16),

6. 11414451 - Floxuridine synthesis (2022-08-16),

7. 11414386 - Process for the preparation of ivacaftor and its intermediates (2022-08-16),

8. 10815202 - Process for the preparation of ivacaftor (2020-10-27),

9. 10774104 - Diastereoselective synthesis of phosphate derivatives (2020-09-15),

10. 10501419 - Processes for the preparation of ivacaftor (2019-12-10),

11. 9834577 - Process for the preparation of gemcitabine-[phenyl(benzoxy-L-alaninyl)] phosphate (2017-12-05),

12. 9573902 - Process for the preparation of Ivacaftor and its intermediates (2017-02-21),

Title: Venkata Lakshmi Narasimha Rao Dammalapati: Innovator in Pharmaceutical Chemistry

Introduction

Venkata Lakshmi Narasimha Rao Dammalapati is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 12 patents. His work focuses on innovative processes and compositions that have the potential to impact cancer treatment and other medical applications.

Latest Patents

Among his latest patents is the invention of a novel crystalline form of nilotinib hydrochloride, along with the process for its preparation and a pharmaceutical composition containing the same. This invention aims to enhance the efficacy and stability of nilotinib, a drug used in cancer therapy. Another notable patent involves the synthesis of phosphate derivatives, specifically a process for preparing certain 5'-phosphoramidate nucleotide diastereoisomers. These phosphoramidates are particularly useful in cancer treatment, including the compound NUC-3373, which is a derivative of 5-fluoro-2′-deoxyuridine.

Career Highlights

Venkata Lakshmi Narasimha Rao Dammalapati has worked with reputable companies in the pharmaceutical industry, including Laurus Labs Private Limited and Nucana Plc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in drug formulation and synthesis.

Collaborations

Throughout his career, he has collaborated with notable professionals in the field, including Mani Bushan Kotala and Suresh Thatipally. These collaborations have fostered a productive environment for research and development, leading to significant breakthroughs in pharmaceutical sciences.

Conclusion

Venkata Lakshmi Narasimha Rao Dammalapati is a distinguished inventor whose work in pharmaceutical chemistry continues to pave the way for innovative treatments. His contributions, particularly in the area of cancer therapy, highlight the importance of research and development in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.